C-peptide measurement is critical in insulin selection for it can reflect islet function of patients, the regimen for patients who use premixed insulin could be considered to use basal insulin if they present higher incidence of hypoglycaemia, greater GV and better islet function. The gene discussed is INS; the disease is Hypoglycemia.